 | • レポートコード：QYR2104Z2641 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、グアイフェネシンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（医薬品有効成分、調剤薬）、用途別市場規模（痰慢性気管支炎、気管支拡張症、感染症、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・グアイフェネシンの市場動向 ・企業の競争状況、市場シェア ・グアイフェネシンの種類別市場規模（医薬品有効成分、調剤薬） ・グアイフェネシンの用途別市場規模（痰慢性気管支炎、気管支拡張症、感染症、その他） ・グアイフェネシンの北米市場規模2016-2027（アメリカ、カナダ） ・グアイフェネシンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・グアイフェネシンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・グアイフェネシンの中南米市場規模2016-2027（メキシコ、ブラジル） ・グアイフェネシンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（EMS Pharmaceutical、Mission Pharma、Orbis Biosciences、Sovereign Pharma、Lipocine Inc、Kowa、RB Pharma、Elan、Granules、Synthokem Labs、Haizhou Pharma、Prasco、Camlin Fine Science、Gennex Lab、Iwaki Seiyaku、Pan Drugs、Smart Pharm、Silarx Pharmaceuticals、Meda Pharmaceuticals (Mylan)、Aurohealth LLC、Enzymatic Therapy、Seven Star Pharma） ・結論 |
Guaiphenesin is also known as Guaifenesin is an expectorant drug usually taken orally to assist the expectoration (‘bringing up’) of phlegm from the airways in acute respiratory tract infections.
Market Analysis and Insights: Global Guaiphenesin Market
The global Guaiphenesin market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Guaiphenesin market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Guaiphenesin market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Guaiphenesin market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Guaiphenesin market.
Global Guaiphenesin Scope and Market Size
Guaiphenesin market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Guaiphenesin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Active Pharmaceutical Ingredients
Preparation
Preparations include tablets ,liquores and syrups.
Segment by Application
Chronic Bronchitis With Phlegm
Bronchiectasis
Infection
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
EMS Pharmaceutical
Mission Pharma
Orbis Biosciences
Sovereign Pharma
Lipocine Inc
Kowa
RB Pharma
Elan
Granules
Synthokem Labs
Haizhou Pharma
Prasco
Camlin Fine Science
Gennex Lab
Iwaki Seiyaku
Pan Drugs
Smart Pharm
Silarx Pharmaceuticals
Meda Pharmaceuticals (Mylan)
Aurohealth LLC
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Guaiphenesin Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Active Pharmaceutical Ingredients
1.2.3 Preparation
1.3 Market by Application
1.3.1 Global Guaiphenesin Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chronic Bronchitis With Phlegm
1.3.3 Bronchiectasis
1.3.4 Infection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Guaiphenesin Market Perspective (2016-2027)
2.2 Guaiphenesin Growth Trends by Regions
2.2.1 Guaiphenesin Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Guaiphenesin Historic Market Share by Regions (2016-2021)
2.2.3 Guaiphenesin Forecasted Market Size by Regions (2022-2027)
2.3 Guaiphenesin Industry Dynamic
2.3.1 Guaiphenesin Market Trends
2.3.2 Guaiphenesin Market Drivers
2.3.3 Guaiphenesin Market Challenges
2.3.4 Guaiphenesin Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Guaiphenesin Players by Revenue
3.1.1 Global Top Guaiphenesin Players by Revenue (2016-2021)
3.1.2 Global Guaiphenesin Revenue Market Share by Players (2016-2021)
3.2 Global Guaiphenesin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Guaiphenesin Revenue
3.4 Global Guaiphenesin Market Concentration Ratio
3.4.1 Global Guaiphenesin Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Guaiphenesin Revenue in 2020
3.5 Guaiphenesin Key Players Head office and Area Served
3.6 Key Players Guaiphenesin Product Solution and Service
3.7 Date of Enter into Guaiphenesin Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Guaiphenesin Breakdown Data by Type
4.1 Global Guaiphenesin Historic Market Size by Type (2016-2021)
4.2 Global Guaiphenesin Forecasted Market Size by Type (2022-2027)
5 Guaiphenesin Breakdown Data by Application
5.1 Global Guaiphenesin Historic Market Size by Application (2016-2021)
5.2 Global Guaiphenesin Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Guaiphenesin Market Size (2016-2027)
6.2 North America Guaiphenesin Market Size by Type
6.2.1 North America Guaiphenesin Market Size by Type (2016-2021)
6.2.2 North America Guaiphenesin Market Size by Type (2022-2027)
6.2.3 North America Guaiphenesin Market Size by Type (2016-2027)
6.3 North America Guaiphenesin Market Size by Application
6.3.1 North America Guaiphenesin Market Size by Application (2016-2021)
6.3.2 North America Guaiphenesin Market Size by Application (2022-2027)
6.3.3 North America Guaiphenesin Market Size by Application (2016-2027)
6.4 North America Guaiphenesin Market Size by Country
6.4.1 North America Guaiphenesin Market Size by Country (2016-2021)
6.4.2 North America Guaiphenesin Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Guaiphenesin Market Size (2016-2027)
7.2 Europe Guaiphenesin Market Size by Type
7.2.1 Europe Guaiphenesin Market Size by Type (2016-2021)
7.2.2 Europe Guaiphenesin Market Size by Type (2022-2027)
7.2.3 Europe Guaiphenesin Market Size by Type (2016-2027)
7.3 Europe Guaiphenesin Market Size by Application
7.3.1 Europe Guaiphenesin Market Size by Application (2016-2021)
7.3.2 Europe Guaiphenesin Market Size by Application (2022-2027)
7.3.3 Europe Guaiphenesin Market Size by Application (2016-2027)
7.4 Europe Guaiphenesin Market Size by Country
7.4.1 Europe Guaiphenesin Market Size by Country (2016-2021)
7.4.2 Europe Guaiphenesin Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Guaiphenesin Market Size (2016-2027)
8.2 Asia-Pacific Guaiphenesin Market Size by Type
8.2.1 Asia-Pacific Guaiphenesin Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Guaiphenesin Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Guaiphenesin Market Size by Type (2016-2027)
8.3 Asia-Pacific Guaiphenesin Market Size by Application
8.3.1 Asia-Pacific Guaiphenesin Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Guaiphenesin Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Guaiphenesin Market Size by Application (2016-2027)
8.4 Asia-Pacific Guaiphenesin Market Size by Region
8.4.1 Asia-Pacific Guaiphenesin Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Guaiphenesin Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Guaiphenesin Market Size (2016-2027)
9.2 Latin America Guaiphenesin Market Size by Type
9.2.1 Latin America Guaiphenesin Market Size by Type (2016-2021)
9.2.2 Latin America Guaiphenesin Market Size by Type (2022-2027)
9.2.3 Latin America Guaiphenesin Market Size by Type (2016-2027)
9.3 Latin America Guaiphenesin Market Size by Application
9.3.1 Latin America Guaiphenesin Market Size by Application (2016-2021)
9.3.2 Latin America Guaiphenesin Market Size by Application (2022-2027)
9.3.3 Latin America Guaiphenesin Market Size by Application (2016-2027)
9.4 Latin America Guaiphenesin Market Size by Country
9.4.1 Latin America Guaiphenesin Market Size by Country (2016-2021)
9.4.2 Latin America Guaiphenesin Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Guaiphenesin Market Size (2016-2027)
10.2 Middle East & Africa Guaiphenesin Market Size by Type
10.2.1 Middle East & Africa Guaiphenesin Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Guaiphenesin Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Guaiphenesin Market Size by Type (2016-2027)
10.3 Middle East & Africa Guaiphenesin Market Size by Application
10.3.1 Middle East & Africa Guaiphenesin Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Guaiphenesin Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Guaiphenesin Market Size by Application (2016-2027)
10.4 Middle East & Africa Guaiphenesin Market Size by Country
10.4.1 Middle East & Africa Guaiphenesin Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Guaiphenesin Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 EMS Pharmaceutical
11.1.1 EMS Pharmaceutical Company Details
11.1.2 EMS Pharmaceutical Business Overview
11.1.3 EMS Pharmaceutical Guaiphenesin Introduction
11.1.4 EMS Pharmaceutical Revenue in Guaiphenesin Business (2016-2021)
11.1.5 EMS Pharmaceutical Recent Development
11.2 Mission Pharma
11.2.1 Mission Pharma Company Details
11.2.2 Mission Pharma Business Overview
11.2.3 Mission Pharma Guaiphenesin Introduction
11.2.4 Mission Pharma Revenue in Guaiphenesin Business (2016-2021)
11.2.5 Mission Pharma Recent Development
11.3 Orbis Biosciences
11.3.1 Orbis Biosciences Company Details
11.3.2 Orbis Biosciences Business Overview
11.3.3 Orbis Biosciences Guaiphenesin Introduction
11.3.4 Orbis Biosciences Revenue in Guaiphenesin Business (2016-2021)
11.3.5 Orbis Biosciences Recent Development
11.4 Sovereign Pharma
11.4.1 Sovereign Pharma Company Details
11.4.2 Sovereign Pharma Business Overview
11.4.3 Sovereign Pharma Guaiphenesin Introduction
11.4.4 Sovereign Pharma Revenue in Guaiphenesin Business (2016-2021)
11.4.5 Sovereign Pharma Recent Development
11.5 Lipocine Inc
11.5.1 Lipocine Inc Company Details
11.5.2 Lipocine Inc Business Overview
11.5.3 Lipocine Inc Guaiphenesin Introduction
11.5.4 Lipocine Inc Revenue in Guaiphenesin Business (2016-2021)
11.5.5 Lipocine Inc Recent Development
11.6 Kowa
11.6.1 Kowa Company Details
11.6.2 Kowa Business Overview
11.6.3 Kowa Guaiphenesin Introduction
11.6.4 Kowa Revenue in Guaiphenesin Business (2016-2021)
11.6.5 Kowa Recent Development
11.7 RB Pharma
11.7.1 RB Pharma Company Details
11.7.2 RB Pharma Business Overview
11.7.3 RB Pharma Guaiphenesin Introduction
11.7.4 RB Pharma Revenue in Guaiphenesin Business (2016-2021)
11.7.5 RB Pharma Recent Development
11.8 Elan
11.8.1 Elan Company Details
11.8.2 Elan Business Overview
11.8.3 Elan Guaiphenesin Introduction
11.8.4 Elan Revenue in Guaiphenesin Business (2016-2021)
11.8.5 Elan Recent Development
11.9 Granules
11.9.1 Granules Company Details
11.9.2 Granules Business Overview
11.9.3 Granules Guaiphenesin Introduction
11.9.4 Granules Revenue in Guaiphenesin Business (2016-2021)
11.9.5 Granules Recent Development
11.10 Synthokem Labs
11.10.1 Synthokem Labs Company Details
11.10.2 Synthokem Labs Business Overview
11.10.3 Synthokem Labs Guaiphenesin Introduction
11.10.4 Synthokem Labs Revenue in Guaiphenesin Business (2016-2021)
11.10.5 Synthokem Labs Recent Development
11.11 Haizhou Pharma
11.11.1 Haizhou Pharma Company Details
11.11.2 Haizhou Pharma Business Overview
11.11.3 Haizhou Pharma Guaiphenesin Introduction
11.11.4 Haizhou Pharma Revenue in Guaiphenesin Business (2016-2021)
11.11.5 Haizhou Pharma Recent Development
11.12 Prasco
11.12.1 Prasco Company Details
11.12.2 Prasco Business Overview
11.12.3 Prasco Guaiphenesin Introduction
11.12.4 Prasco Revenue in Guaiphenesin Business (2016-2021)
11.12.5 Prasco Recent Development
11.13 Camlin Fine Science
11.13.1 Camlin Fine Science Company Details
11.13.2 Camlin Fine Science Business Overview
11.13.3 Camlin Fine Science Guaiphenesin Introduction
11.13.4 Camlin Fine Science Revenue in Guaiphenesin Business (2016-2021)
11.13.5 Camlin Fine Science Recent Development
11.14 Gennex Lab
11.14.1 Gennex Lab Company Details
11.14.2 Gennex Lab Business Overview
11.14.3 Gennex Lab Guaiphenesin Introduction
11.14.4 Gennex Lab Revenue in Guaiphenesin Business (2016-2021)
11.14.5 Gennex Lab Recent Development
11.15 Iwaki Seiyaku
11.15.1 Iwaki Seiyaku Company Details
11.15.2 Iwaki Seiyaku Business Overview
11.15.3 Iwaki Seiyaku Guaiphenesin Introduction
11.15.4 Iwaki Seiyaku Revenue in Guaiphenesin Business (2016-2021)
11.15.5 Iwaki Seiyaku Recent Development
11.16 Pan Drugs
11.16.1 Pan Drugs Company Details
11.16.2 Pan Drugs Business Overview
11.16.3 Pan Drugs Guaiphenesin Introduction
11.16.4 Pan Drugs Revenue in Guaiphenesin Business (2016-2021)
11.16.5 Pan Drugs Recent Development
11.17 Smart Pharm
11.17.1 Smart Pharm Company Details
11.17.2 Smart Pharm Business Overview
11.17.3 Smart Pharm Guaiphenesin Introduction
11.17.4 Smart Pharm Revenue in Guaiphenesin Business (2016-2021)
11.17.5 Smart Pharm Recent Development
11.18 Silarx Pharmaceuticals
11.18.1 Silarx Pharmaceuticals Company Details
11.18.2 Silarx Pharmaceuticals Business Overview
11.18.3 Silarx Pharmaceuticals Guaiphenesin Introduction
11.18.4 Silarx Pharmaceuticals Revenue in Guaiphenesin Business (2016-2021)
11.18.5 Silarx Pharmaceuticals Recent Development
11.18 Meda Pharmaceuticals (Mylan)
.1 Meda Pharmaceuticals (Mylan) Company Details
.2 Meda Pharmaceuticals (Mylan) Business Overview
.3 Meda Pharmaceuticals (Mylan) Guaiphenesin Introduction
.4 Meda Pharmaceuticals (Mylan) Revenue in Guaiphenesin Business (2016-2021)
.5 Meda Pharmaceuticals (Mylan) Recent Development
11.20 Aurohealth LLC
11.20.1 Aurohealth LLC Company Details
11.20.2 Aurohealth LLC Business Overview
11.20.3 Aurohealth LLC Guaiphenesin Introduction
11.20.4 Aurohealth LLC Revenue in Guaiphenesin Business (2016-2021)
11.20.5 Aurohealth LLC Recent Development
11.21 Enzymatic Therapy
11.21.1 Enzymatic Therapy Company Details
11.21.2 Enzymatic Therapy Business Overview
11.21.3 Enzymatic Therapy Guaiphenesin Introduction
11.21.4 Enzymatic Therapy Revenue in Guaiphenesin Business (2016-2021)
11.21.5 Enzymatic Therapy Recent Development
11.22 Seven Star Pharma
11.22.1 Seven Star Pharma Company Details
11.22.2 Seven Star Pharma Business Overview
11.22.3 Seven Star Pharma Guaiphenesin Introduction
11.22.4 Seven Star Pharma Revenue in Guaiphenesin Business (2016-2021)
11.22.5 Seven Star Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Guaiphenesin Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Active Pharmaceutical Ingredients
Table 3. Key Players of Preparation
Table 4. Global Guaiphenesin Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Guaiphenesin Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Guaiphenesin Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Guaiphenesin Market Share by Regions (2016-2021)
Table 8. Global Guaiphenesin Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Guaiphenesin Market Share by Regions (2022-2027)
Table 10. Guaiphenesin Market Trends
Table 11. Guaiphenesin Market Drivers
Table 12. Guaiphenesin Market Challenges
Table 13. Guaiphenesin Market Restraints
Table 14. Global Guaiphenesin Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Guaiphenesin Market Share by Players (2016-2021)
Table 16. Global Top Guaiphenesin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaiphenesin as of 2020)
Table 17. Ranking of Global Top Guaiphenesin Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Guaiphenesin Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Guaiphenesin Product Solution and Service
Table 21. Date of Enter into Guaiphenesin Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Guaiphenesin Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Guaiphenesin Revenue Market Share by Type (2016-2021)
Table 25. Global Guaiphenesin Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Guaiphenesin Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Guaiphenesin Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Guaiphenesin Revenue Market Share by Application (2016-2021)
Table 29. Global Guaiphenesin Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Guaiphenesin Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Guaiphenesin Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Guaiphenesin Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Guaiphenesin Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Guaiphenesin Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Guaiphenesin Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Guaiphenesin Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Guaiphenesin Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Guaiphenesin Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Guaiphenesin Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Guaiphenesin Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Guaiphenesin Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Guaiphenesin Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Guaiphenesin Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Guaiphenesin Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Guaiphenesin Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Guaiphenesin Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Guaiphenesin Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Guaiphenesin Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Guaiphenesin Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Guaiphenesin Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Guaiphenesin Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Guaiphenesin Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Guaiphenesin Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Guaiphenesin Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Guaiphenesin Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Guaiphenesin Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Guaiphenesin Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Guaiphenesin Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Guaiphenesin Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Guaiphenesin Market Size by Country (2022-2027) & (US$ Million)
Table 61. EMS Pharmaceutical Company Details
Table 62. EMS Pharmaceutical Business Overview
Table 63. EMS Pharmaceutical Guaiphenesin Product
Table 64. EMS Pharmaceutical Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 65. EMS Pharmaceutical Recent Development
Table 66. Mission Pharma Company Details
Table 67. Mission Pharma Business Overview
Table 68. Mission Pharma Guaiphenesin Product
Table 69. Mission Pharma Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 70. Mission Pharma Recent Development
Table 71. Orbis Biosciences Company Details
Table 72. Orbis Biosciences Business Overview
Table 73. Orbis Biosciences Guaiphenesin Product
Table 74. Orbis Biosciences Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 75. Orbis Biosciences Recent Development
Table 76. Sovereign Pharma Company Details
Table 77. Sovereign Pharma Business Overview
Table 78. Sovereign Pharma Guaiphenesin Product
Table 79. Sovereign Pharma Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 80. Sovereign Pharma Recent Development
Table 81. Lipocine Inc Company Details
Table 82. Lipocine Inc Business Overview
Table 83. Lipocine Inc Guaiphenesin Product
Table 84. Lipocine Inc Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 85. Lipocine Inc Recent Development
Table 86. Kowa Company Details
Table 87. Kowa Business Overview
Table 88. Kowa Guaiphenesin Product
Table 89. Kowa Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 90. Kowa Recent Development
Table 91. RB Pharma Company Details
Table 92. RB Pharma Business Overview
Table 93. RB Pharma Guaiphenesin Product
Table 94. RB Pharma Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 95. RB Pharma Recent Development
Table 96. Elan Company Details
Table 97. Elan Business Overview
Table 98. Elan Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 99. Elan Recent Development
Table 100. Granules Company Details
Table 101. Granules Business Overview
Table 102. Granules Guaiphenesin Product
Table 103. Granules Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 104. Granules Recent Development
Table 105. Synthokem Labs Company Details
Table 106. Synthokem Labs Business Overview
Table 107. Synthokem Labs Guaiphenesin Product
Table 108. Synthokem Labs Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 109. Synthokem Labs Recent Development
Table 110. Haizhou Pharma Company Details
Table 111. Haizhou Pharma Business Overview
Table 112. Haizhou Pharma Guaiphenesin Product
Table 113. Haizhou Pharma Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 114. Haizhou Pharma Recent Development
Table 115. Prasco Company Details
Table 116. Prasco Business Overview
Table 117. Prasco Guaiphenesin Product
Table 118. Prasco Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 119. Prasco Recent Development
Table 120. Camlin Fine Science Company Details
Table 121. Camlin Fine Science Business Overview
Table 122. Camlin Fine Science Guaiphenesin Product
Table 123. Camlin Fine Science Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 124. Camlin Fine Science Recent Development
Table 125. Gennex Lab Company Details
Table 126. Gennex Lab Business Overview
Table 127. Gennex Lab Guaiphenesin Product
Table 128. Gennex Lab Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 129. Gennex Lab Recent Development
Table 130. Iwaki Seiyaku Company Details
Table 131. Iwaki Seiyaku Business Overview
Table 132. Iwaki Seiyaku Guaiphenesin Product
Table 133. Iwaki Seiyaku Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 134. Iwaki Seiyaku Recent Development
Table 135. Pan Drugs Company Details
Table 136. Pan Drugs Business Overview
Table 137. Pan Drugs Guaiphenesin Product
Table 138. Pan Drugs Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 139. Pan Drugs Recent Development
Table 140. Smart Pharm Company Details
Table 141. Smart Pharm Business Overview
Table 142. Smart Pharm Guaiphenesin Product
Table 143. Smart Pharm Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 144. Smart Pharm Recent Development
Table 145. Silarx Pharmaceuticals Company Details
Table 146. Silarx Pharmaceuticals Business Overview
Table 147. Silarx Pharmaceuticals Guaiphenesin Product
Table 148. Silarx Pharmaceuticals Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 149. Silarx Pharmaceuticals Recent Development
Table 150. Meda Pharmaceuticals (Mylan) Company Details
Table 151. Meda Pharmaceuticals (Mylan) Business Overview
Table 152. Meda Pharmaceuticals (Mylan) Guaiphenesin Product
Table 153. Meda Pharmaceuticals (Mylan) Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 154. Meda Pharmaceuticals (Mylan) Recent Development
Table 155. Aurohealth LLC Company Details
Table 156. Aurohealth LLC Business Overview
Table 157. Aurohealth LLC Guaiphenesin Product
Table 158. Aurohealth LLC Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 159. Aurohealth LLC Recent Development
Table 160. Enzymatic Therapy Company Details
Table 161. Enzymatic Therapy Business Overview
Table 162. Enzymatic Therapy Guaiphenesin Product
Table 163. Enzymatic Therapy Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 164. Enzymatic Therapy Recent Development
Table 165. Seven Star Pharma Company Details
Table 166. Seven Star Pharma Business Overview
Table 167. Seven Star Pharma Guaiphenesin Product
Table 168. Seven Star Pharma Revenue in Guaiphenesin Business (2016-2021) & (US$ Million)
Table 169. Seven Star Pharma Recent Development
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Guaiphenesin Market Share by Type: 2020 VS 2027
Figure 2. Active Pharmaceutical Ingredients Features
Figure 3. Preparation Features
Figure 4. Global Guaiphenesin Market Share by Application: 2020 VS 2027
Figure 5. Chronic Bronchitis With Phlegm Case Studies
Figure 6. Bronchiectasis Case Studies
Figure 7. Infection Case Studies
Figure 8. Other Case Studies
Figure 9. Guaiphenesin Report Years Considered
Figure 10. Global Guaiphenesin Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Guaiphenesin Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Guaiphenesin Market Share by Regions: 2020 VS 2027
Figure 13. Global Guaiphenesin Market Share by Regions (2022-2027)
Figure 14. Global Guaiphenesin Market Share by Players in 2020
Figure 15. Global Top Guaiphenesin Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Guaiphenesin as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Guaiphenesin Revenue in 2020
Figure 17. Global Guaiphenesin Revenue Market Share by Type (2016-2021)
Figure 18. Global Guaiphenesin Revenue Market Share by Type (2022-2027)
Figure 19. North America Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Guaiphenesin Market Share by Type (2016-2027)
Figure 21. North America Guaiphenesin Market Share by Application (2016-2027)
Figure 22. North America Guaiphenesin Market Share by Country (2016-2027)
Figure 23. United States Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Guaiphenesin Market Share by Type (2016-2027)
Figure 27. Europe Guaiphenesin Market Share by Application (2016-2027)
Figure 28. Europe Guaiphenesin Market Share by Country (2016-2027)
Figure 29. Germany Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Guaiphenesin Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Guaiphenesin Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Guaiphenesin Market Share by Region (2016-2027)
Figure 39. China Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Guaiphenesin Market Share by Type (2016-2027)
Figure 47. Latin America Guaiphenesin Market Share by Application (2016-2027)
Figure 48. Latin America Guaiphenesin Market Share by Country (2016-2027)
Figure 49. Mexico Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Guaiphenesin Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Guaiphenesin Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Guaiphenesin Market Share by Country (2016-2027)
Figure 55. Turkey Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Guaiphenesin Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. EMS Pharmaceutical Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 59. Mission Pharma Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 60. Orbis Biosciences Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 61. Sovereign Pharma Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 62. Lipocine Inc Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 63. Kowa Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 64. RB Pharma Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 65. Elan Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 66. Granules Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 67. Synthokem Labs Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 68. Haizhou Pharma Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 69. Prasco Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 70. Camlin Fine Science Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 71. Gennex Lab Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 72. Iwaki Seiyaku Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 73. Pan Drugs Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 74. Smart Pharm Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 75. Silarx Pharmaceuticals Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 76. Meda Pharmaceuticals (Mylan) Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 77. Aurohealth LLC Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 78. Enzymatic Therapy Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 79. Seven Star Pharma Revenue Growth Rate in Guaiphenesin Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界の気管支拡張症治療市場規模・現状・予測（2021年-2027年） Bronchiectasis refers to a condition characterized by damaged airways (tubes) and affect their ability to clear out the mucus. This deposition of mucus leads to bacterial infections and hence resulting in serious and repeated lung infections. Bronchiectasis is a long term condition resulting in seri…- 世界の気管支炎市場規模・現状・予測（2021年-2027年） Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. Symptoms include coughing up mucus, wheezing, shortness of breath, and chest discomfort. Bronchitis is divided into two types: acute and chronic. Acute bronchitis is also known as a chest cold. Market Analysis a…
- 世界の気管支炎治療市場規模・現状・予測（2021年-2027年） Bronchitis is a respiratory disease in which there is inflammation of the bronchi in the lungs. In other words, bronchitis is an inflammation of the lining of bronchial tubes that carry air to and from the lungs. Some of the common signs and symptoms of bronchitis include cough, fatigue, shortness o…
- 世界の新有効成分食品カプセル化市場規模・現状・予測（2021年-2027年） Organic structures consumed in food are packaged in units that carry the active ingredients and protect the encapsulated active substances until they are shipped to the food. In the future, nutritional supplements and functional foods may be tailored to individual metabolic needs and related to the …
- 世界のヘパリン有効成分市場 2021：企業別、地域別、種類・用途別 The Heparin Active Pharmaceutical Ingredients market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…